Global And Japan Influenza Drugs And Vaccines Market Insights, Forecast To 2027

1 Study Coverage
1.1 Influenza Drugs and Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Influenza Drugs and Vaccines Market Size Growth Rate by Type
1.2.2 Influenza Drugs
1.2.3 Influenza Vaccines
1.3 Market by Application
1.3.1 Global Influenza Drugs and Vaccines Market Size Growth Rate by Application
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Influenza Drugs and Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Influenza Drugs and Vaccines Revenue 2016-2027
2.1.2 Global Influenza Drugs and Vaccines Sales 2016-2027
2.2 Global Influenza Drugs and Vaccines, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Influenza Drugs and Vaccines Historical Market Size by Region (2016-2021)
2.3.1 Global Influenza Drugs and Vaccines Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Influenza Drugs and Vaccines Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Influenza Drugs and Vaccines Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Influenza Drugs and Vaccines Sales Forecast by Region (2022-2027)
2.4.2 Global Influenza Drugs and Vaccines Revenue Forecast by Region (2022-2027)

3 Global Influenza Drugs and Vaccines Competitor Landscape by Players
3.1 Global Top Influenza Drugs and Vaccines Manufacturers by Sales
3.1.1 Global Influenza Drugs and Vaccines Sales by Manufacturer (2016-2021)
3.1.2 Global Influenza Drugs and Vaccines Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Influenza Drugs and Vaccines Manufacturers by Revenue
3.2.1 Key Influenza Drugs and Vaccines Manufacturers Covered: Ranking by Revenue
3.2.2 Global Influenza Drugs and Vaccines Revenue by Manufacturers (2016-2021)
3.2.3 Global Influenza Drugs and Vaccines Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Influenza Drugs and Vaccines Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Influenza Drugs and Vaccines Revenue in 2020
3.2.6 Global Influenza Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Influenza Drugs and Vaccines Price by Manufacturers
3.4 Global Influenza Drugs and Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Influenza Drugs and Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Influenza Drugs and Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Influenza Drugs and Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Influenza Drugs and Vaccines Market Size by Type (2016-2021)
4.1.1 Global Influenza Drugs and Vaccines Sales by Type (2016-2021)
4.1.2 Global Influenza Drugs and Vaccines Revenue by Type (2016-2021)
4.1.3 Influenza Drugs and Vaccines Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Influenza Drugs and Vaccines Market Size Forecast by Type (2022-2027)
4.2.1 Global Influenza Drugs and Vaccines Sales Forecast by Type (2022-2027)
4.2.2 Global Influenza Drugs and Vaccines Revenue Forecast by Type (2022-2027)
4.2.3 Influenza Drugs and Vaccines Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Influenza Drugs and Vaccines Market Size by Application (2016-2021)
5.1.1 Global Influenza Drugs and Vaccines Sales by Application (2016-2021)
5.1.2 Global Influenza Drugs and Vaccines Revenue by Application (2016-2021)
5.1.3 Influenza Drugs and Vaccines Price by Application (2016-2021)
5.2 Influenza Drugs and Vaccines Market Size Forecast by Application (2022-2027)
5.2.1 Global Influenza Drugs and Vaccines Sales Forecast by Application (2022-2027)
5.2.2 Global Influenza Drugs and Vaccines Revenue Forecast by Application (2022-2027)
5.2.3 Global Influenza Drugs and Vaccines Price Forecast by Application (2022-2027)

6 Japan by Players, Type and Application
6.1 Japan Influenza Drugs and Vaccines Market Size YoY Growth 2016-2027
6.1.1 Japan Influenza Drugs and Vaccines Sales YoY Growth 2016-2027
6.1.2 Japan Influenza Drugs and Vaccines Revenue YoY Growth 2016-2027
6.1.3 Japan Influenza Drugs and Vaccines Market Share in Global Market 2016-2027
6.2 Japan Influenza Drugs and Vaccines Market Size by Players (International and Local Players)
6.2.1 Japan Top Influenza Drugs and Vaccines Players by Sales (2016-2021)
6.2.2 Japan Top Influenza Drugs and Vaccines Players by Revenue (2016-2021)
6.3 Japan Influenza Drugs and Vaccines Historic Market Review by Type (2016-2021)
6.3.1 Japan Influenza Drugs and Vaccines Sales Market Share by Type (2016-2021)
6.3.2 Japan Influenza Drugs and Vaccines Revenue Market Share by Type (2016-2021)
6.3.3 Japan Influenza Drugs and Vaccines Price by Type (2016-2021)
6.4 Japan Influenza Drugs and Vaccines Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Influenza Drugs and Vaccines Sales Forecast by Type (2022-2027)
6.4.2 Japan Influenza Drugs and Vaccines Revenue Forecast by Type (2022-2027)
6.4.3 Japan Influenza Drugs and Vaccines Price Forecast by Type (2022-2027)
6.5 Japan Influenza Drugs and Vaccines Historic Market Review by Application (2016-2021)
6.5.1 Japan Influenza Drugs and Vaccines Sales Market Share by Application (2016-2021)
6.5.2 Japan Influenza Drugs and Vaccines Revenue Market Share by Application (2016-2021)
6.5.3 Japan Influenza Drugs and Vaccines Price by Application (2016-2021)
6.6 Japan Influenza Drugs and Vaccines Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Influenza Drugs and Vaccines Sales Forecast by Application (2022-2027)
6.6.2 Japan Influenza Drugs and Vaccines Revenue Forecast by Application (2022-2027)
6.6.3 Japan Influenza Drugs and Vaccines Price Forecast by Application (2022-2027)

7 North America
7.1 North America Influenza Drugs and Vaccines Market Size YoY Growth 2016-2027
7.2 North America Influenza Drugs and Vaccines Market Facts & Figures by Country
7.2.1 North America Influenza Drugs and Vaccines Sales by Country (2016-2021)
7.2.2 North America Influenza Drugs and Vaccines Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Influenza Drugs and Vaccines Market Size YoY Growth 2016-2027
8.2 Asia Pacific Influenza Drugs and Vaccines Market Facts & Figures by Region
8.2.1 Asia Pacific Influenza Drugs and Vaccines Sales by Region (2016-2021)
8.2.2 Asia Pacific Influenza Drugs and Vaccines Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Influenza Drugs and Vaccines Market Size YoY Growth 2016-2027
9.2 Europe Influenza Drugs and Vaccines Market Facts & Figures by Country
9.2.1 Europe Influenza Drugs and Vaccines Sales by Country (2016-2021)
9.2.2 Europe Influenza Drugs and Vaccines Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Influenza Drugs and Vaccines Market Size YoY Growth 2016-2027
10.2 Latin America Influenza Drugs and Vaccines Market Facts & Figures by Country
10.2.1 Latin America Influenza Drugs and Vaccines Sales by Country (2016-2021)
10.2.2 Latin America Influenza Drugs and Vaccines Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Influenza Drugs and Vaccines Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Influenza Drugs and Vaccines Market Facts & Figures by Country
11.2.1 Middle East and Africa Influenza Drugs and Vaccines Sales by Country (2016-2021)
11.2.2 Middle East and Africa Influenza Drugs and Vaccines Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Bristol Myers Squibb
12.1.1 Bristol Myers Squibb Corporation Information
12.1.2 Bristol Myers Squibb Description and Business Overview
12.1.3 Bristol Myers Squibb Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Bristol Myers Squibb Influenza Drugs and Vaccines Products Offered
12.1.5 Bristol Myers Squibb Recent Development
12.2 AstraZeneca
12.2.1 AstraZeneca Corporation Information
12.2.2 AstraZeneca Description and Business Overview
12.2.3 AstraZeneca Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.2.4 AstraZeneca Influenza Drugs and Vaccines Products Offered
12.2.5 AstraZeneca Recent Development
12.3 Eli Lilly
12.3.1 Eli Lilly Corporation Information
12.3.2 Eli Lilly Description and Business Overview
12.3.3 Eli Lilly Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Eli Lilly Influenza Drugs and Vaccines Products Offered
12.3.5 Eli Lilly Recent Development
12.4 Roche
12.4.1 Roche Corporation Information
12.4.2 Roche Description and Business Overview
12.4.3 Roche Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Roche Influenza Drugs and Vaccines Products Offered
12.4.5 Roche Recent Development
12.5 GlaxoSmithKline
12.5.1 GlaxoSmithKline Corporation Information
12.5.2 GlaxoSmithKline Description and Business Overview
12.5.3 GlaxoSmithKline Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.5.4 GlaxoSmithKline Influenza Drugs and Vaccines Products Offered
12.5.5 GlaxoSmithKline Recent Development
12.6 Novartis
12.6.1 Novartis Corporation Information
12.6.2 Novartis Description and Business Overview
12.6.3 Novartis Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Novartis Influenza Drugs and Vaccines Products Offered
12.6.5 Novartis Recent Development
12.7 Pfizer
12.7.1 Pfizer Corporation Information
12.7.2 Pfizer Description and Business Overview
12.7.3 Pfizer Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Pfizer Influenza Drugs and Vaccines Products Offered
12.7.5 Pfizer Recent Development
12.8 Sanofi Pasteur
12.8.1 Sanofi Pasteur Corporation Information
12.8.2 Sanofi Pasteur Description and Business Overview
12.8.3 Sanofi Pasteur Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Sanofi Pasteur Influenza Drugs and Vaccines Products Offered
12.8.5 Sanofi Pasteur Recent Development
12.9 Bayer
12.9.1 Bayer Corporation Information
12.9.2 Bayer Description and Business Overview
12.9.3 Bayer Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Bayer Influenza Drugs and Vaccines Products Offered
12.9.5 Bayer Recent Development
12.10 Celgene
12.10.1 Celgene Corporation Information
12.10.2 Celgene Description and Business Overview
12.10.3 Celgene Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Celgene Influenza Drugs and Vaccines Products Offered
12.10.5 Celgene Recent Development
12.11 Bristol Myers Squibb
12.11.1 Bristol Myers Squibb Corporation Information
12.11.2 Bristol Myers Squibb Description and Business Overview
12.11.3 Bristol Myers Squibb Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Bristol Myers Squibb Influenza Drugs and Vaccines Products Offered
12.11.5 Bristol Myers Squibb Recent Development
12.12 Protein Sciences Corporation
12.12.1 Protein Sciences Corporation Corporation Information
12.12.2 Protein Sciences Corporation Description and Business Overview
12.12.3 Protein Sciences Corporation Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Protein Sciences Corporation Products Offered
12.12.5 Protein Sciences Corporation Recent Development
12.13 Serum Institute of India
12.13.1 Serum Institute of India Corporation Information
12.13.2 Serum Institute of India Description and Business Overview
12.13.3 Serum Institute of India Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Serum Institute of India Products Offered
12.13.5 Serum Institute of India Recent Development
12.14 Emergent Biosolutions
12.14.1 Emergent Biosolutions Corporation Information
12.14.2 Emergent Biosolutions Description and Business Overview
12.14.3 Emergent Biosolutions Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Emergent Biosolutions Products Offered
12.14.5 Emergent Biosolutions Recent Development
12.15 BioCryst Pharmaceuticals
12.15.1 BioCryst Pharmaceuticals Corporation Information
12.15.2 BioCryst Pharmaceuticals Description and Business Overview
12.15.3 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.15.4 BioCryst Pharmaceuticals Products Offered
12.15.5 BioCryst Pharmaceuticals Recent Development
12.16 Alvogen
12.16.1 Alvogen Corporation Information
12.16.2 Alvogen Description and Business Overview
12.16.3 Alvogen Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Alvogen Products Offered
12.16.5 Alvogen Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Influenza Drugs and Vaccines Industry Trends
13.2 Influenza Drugs and Vaccines Market Drivers
13.3 Influenza Drugs and Vaccines Market Challenges
13.4 Influenza Drugs and Vaccines Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Influenza Drugs and Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Influenza Drugs and Vaccines Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Influenza Drugs
Table 3. Major Manufacturers of Influenza Vaccines
Table 4. Global Influenza Drugs and Vaccines Market Size Growth Rate by Application (2021-2027) & (MT)
Table 5. Global Influenza Drugs and Vaccines Market Size by Region (MT) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Influenza Drugs and Vaccines Sales by Regions (2016-2021) & (MT)
Table 7. Global Influenza Drugs and Vaccines Sales Market Share by Regions (2016-2021)
Table 8. Global Influenza Drugs and Vaccines Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Influenza Drugs and Vaccines Sales Forecast by Region (2022-2027) & (MT)
Table 10. Global Influenza Drugs and Vaccines Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Influenza Drugs and Vaccines Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Influenza Drugs and Vaccines Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Influenza Drugs and Vaccines Sales by Manufacturers (2016-2021) (MT)
Table 14. Global Influenza Drugs and Vaccines Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Influenza Drugs and Vaccines Manufacturers by Revenue (US$ Million) in 2020
Table 16. Influenza Drugs and Vaccines Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Influenza Drugs and Vaccines Revenue Share by Manufacturers (2016-2021)
Table 18. Global Influenza Drugs and Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Influenza Drugs and Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Drugs and Vaccines as of 2020)
Table 20. Key Manufacturers Influenza Drugs and Vaccines Price (2016-2021) (USD/Kg)
Table 21. Influenza Drugs and Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Influenza Drugs and Vaccines Product Type
Table 23. Date of International Manufacturers Enter into Influenza Drugs and Vaccines Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Influenza Drugs and Vaccines Sales by Type (2016-2021) (MT)
Table 26. Global Influenza Drugs and Vaccines Sales Share by Type (2016-2021)
Table 27. Global Influenza Drugs and Vaccines Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Influenza Drugs and Vaccines Revenue Share by Type (2016-2021)
Table 29. Influenza Drugs and Vaccines Average Selling Price (ASP) by Type (2016-2021) & (USD/Kg)
Table 30. Global Influenza Drugs and Vaccines Sales Forecast by Type (2022-2027) & (MT)
Table 31. Global Influenza Drugs and Vaccines Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Influenza Drugs and Vaccines Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Influenza Drugs and Vaccines Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Influenza Drugs and Vaccines Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Kg)
Table 35. Global Influenza Drugs and Vaccines Sales by Application (2016-2021) (MT)
Table 36. Global Influenza Drugs and Vaccines Sales Share by Application (2016-2021)
Table 37. Global Influenza Drugs and Vaccines Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Influenza Drugs and Vaccines Revenue Share by Application (2016-2021)
Table 39. Influenza Drugs and Vaccines Average Selling Price (ASP) by Application (2016-2021) & (USD/Kg)
Table 40. Global Influenza Drugs and Vaccines Sales Forecast by Application (2022-2027) & (MT)
Table 41. Global Influenza Drugs and Vaccines Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Influenza Drugs and Vaccines Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Influenza Drugs and Vaccines Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Influenza Drugs and Vaccines Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Kg)
Table 45. Japan Influenza Drugs and Vaccines Sales (MT) of Key Companies (2016-2021)
Table 46. Japan Influenza Drugs and Vaccines Sales Share by Company (2016-2021)
Table 47. Japan Influenza Drugs and Vaccines Revenue (US$ Million) by Company (2016-2021)
Table 48. Japan Influenza Drugs and Vaccines Revenue Share by Company (2016-2021)
Table 49. Japan Influenza Drugs and Vaccines Sales (MT) by Type (2016-2021)
Table 50. Japan Influenza Drugs and Vaccines Sales Share by Type (2016-2021)
Table 51. Japan Influenza Drugs and Vaccines Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. Japan Influenza Drugs and Vaccines Price (USD/Kg) by Type (2016-2021)
Table 53. Japan Influenza Drugs and Vaccines Sales (MT) by Type (2022-2027)
Table 54. Japan Influenza Drugs and Vaccines Sales Share by Type (2022-2027)
Table 55. Japan Influenza Drugs and Vaccines Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. Japan Influenza Drugs and Vaccines Revenue Share by Type (2022-2027)
Table 57. Japan Influenza Drugs and Vaccines Price (USD/Kg) by Type (2022-2027)
Table 58. Japan Influenza Drugs and Vaccines Sales (MT) by Application (2016-2021)
Table 59. Japan Influenza Drugs and Vaccines Sales Share by Application (2016-2021)
Table 60. Japan Influenza Drugs and Vaccines Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. Japan Influenza Drugs and Vaccines Price (USD/Kg) by Application (2016-2021)
Table 62. Japan Influenza Drugs and Vaccines Sales (MT) by Application (2022-2027)
Table 63. Japan Influenza Drugs and Vaccines Sales Share by Application (2022-2027)
Table 64. Japan Influenza Drugs and Vaccines Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. Japan Influenza Drugs and Vaccines Revenue Share by Application (2022-2027)
Table 66. Japan Influenza Drugs and Vaccines Price (USD/Kg) by Application (2022-2027)
Table 67. North America Influenza Drugs and Vaccines Sales by Country (2016-2021) & (MT)
Table 68. North America Influenza Drugs and Vaccines Sales Market Share by Country (2016-2021)
Table 69. North America Influenza Drugs and Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Influenza Drugs and Vaccines Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Influenza Drugs and Vaccines Sales by Region (2016-2021) & (MT)
Table 72. Asia Pacific Influenza Drugs and Vaccines Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Influenza Drugs and Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Influenza Drugs and Vaccines Revenue Market Share by Region (2016-2021)
Table 75. Europe Influenza Drugs and Vaccines Sales by Country (2016-2021) & (MT)
Table 76. Europe Influenza Drugs and Vaccines Sales Market Share by Country (2016-2021)
Table 77. Europe Influenza Drugs and Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Influenza Drugs and Vaccines Revenue Market Share by Country (2016-2021)
Table 79. Latin America Influenza Drugs and Vaccines Sales by Country (2016-2021) & (MT)
Table 80. Latin America Influenza Drugs and Vaccines Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Influenza Drugs and Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Influenza Drugs and Vaccines Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Influenza Drugs and Vaccines Sales by Country (2016-2021) & (MT)
Table 84. Middle East and Africa Influenza Drugs and Vaccines Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Influenza Drugs and Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Influenza Drugs and Vaccines Revenue Market Share by Country (2016-2021)
Table 87. Bristol Myers Squibb Corporation Information
Table 88. Bristol Myers Squibb Description and Business Overview
Table 89. Bristol Myers Squibb Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 90. Bristol Myers Squibb Influenza Drugs and Vaccines Product
Table 91. Bristol Myers Squibb Recent Development
Table 92. AstraZeneca Corporation Information
Table 93. AstraZeneca Description and Business Overview
Table 94. AstraZeneca Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 95. AstraZeneca Product
Table 96. AstraZeneca Recent Development
Table 97. Eli Lilly Corporation Information
Table 98. Eli Lilly Description and Business Overview
Table 99. Eli Lilly Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 100. Eli Lilly Product
Table 101. Eli Lilly Recent Development
Table 102. Roche Corporation Information
Table 103. Roche Description and Business Overview
Table 104. Roche Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 105. Roche Product
Table 106. Roche Recent Development
Table 107. GlaxoSmithKline Corporation Information
Table 108. GlaxoSmithKline Description and Business Overview
Table 109. GlaxoSmithKline Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 110. GlaxoSmithKline Product
Table 111. GlaxoSmithKline Recent Development
Table 112. Novartis Corporation Information
Table 113. Novartis Description and Business Overview
Table 114. Novartis Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 115. Novartis Product
Table 116. Novartis Recent Development
Table 117. Pfizer Corporation Information
Table 118. Pfizer Description and Business Overview
Table 119. Pfizer Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 120. Pfizer Product
Table 121. Pfizer Recent Development
Table 122. Sanofi Pasteur Corporation Information
Table 123. Sanofi Pasteur Description and Business Overview
Table 124. Sanofi Pasteur Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 125. Sanofi Pasteur Product
Table 126. Sanofi Pasteur Recent Development
Table 127. Bayer Corporation Information
Table 128. Bayer Description and Business Overview
Table 129. Bayer Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 130. Bayer Product
Table 131. Bayer Recent Development
Table 132. Celgene Corporation Information
Table 133. Celgene Description and Business Overview
Table 134. Celgene Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 135. Celgene Product
Table 136. Celgene Recent Development
Table 137. Seqirus Corporation Information
Table 138. Seqirus Description and Business Overview
Table 139. Seqirus Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 140. Seqirus Product
Table 141. Seqirus Recent Development
Table 142. Protein Sciences Corporation Corporation Information
Table 143. Protein Sciences Corporation Description and Business Overview
Table 144. Protein Sciences Corporation Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 145. Protein Sciences Corporation Product
Table 146. Protein Sciences Corporation Recent Development
Table 147. Serum Institute of India Corporation Information
Table 148. Serum Institute of India Description and Business Overview
Table 149. Serum Institute of India Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 150. Serum Institute of India Product
Table 151. Serum Institute of India Recent Development
Table 152. Emergent Biosolutions Corporation Information
Table 153. Emergent Biosolutions Description and Business Overview
Table 154. Emergent Biosolutions Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 155. Emergent Biosolutions Product
Table 156. Emergent Biosolutions Recent Development
Table 157. BioCryst Pharmaceuticals Corporation Information
Table 158. BioCryst Pharmaceuticals Description and Business Overview
Table 159. BioCryst Pharmaceuticals Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 160. BioCryst Pharmaceuticals Product
Table 161. BioCryst Pharmaceuticals Recent Development
Table 162. Alvogen Corporation Information
Table 163. Alvogen Description and Business Overview
Table 164. Alvogen Influenza Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 165. Alvogen Product
Table 166. Alvogen Recent Development
Table 167. Influenza Drugs and Vaccines Market Trends
Table 168. Influenza Drugs and Vaccines Market Drivers
Table 169. Influenza Drugs and Vaccines Market Challenges
Table 170. Influenza Drugs and Vaccines Market Restraints
Table 171. Influenza Drugs and Vaccines Customers List
Table 172. Influenza Drugs and Vaccines Distributors List
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Influenza Drugs and Vaccines Product Picture
Figure 2. Global Influenza Drugs and Vaccines Sales Market Share by Type in 2020 & 2027
Figure 3. Influenza Drugs Product Picture
Figure 4. Influenza Vaccines Product Picture
Figure 5. Global Influenza Drugs and Vaccines Sales Market Share by Application in 2020 & 2027
Figure 6. Hospital Pharmacy
Figure 7. Retail Pharmacy
Figure 8. Online Pharmacy
Figure 9. Influenza Drugs and Vaccines Report Years Considered
Figure 10. Global Influenza Drugs and Vaccines Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Influenza Drugs and Vaccines Market Size 2016-2027 (US$ Million)
Figure 12. Global Influenza Drugs and Vaccines Sales 2016-2027 (MT)
Figure 13. Global Influenza Drugs and Vaccines Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global Influenza Drugs and Vaccines Sales Market Share by Region (2016-2021)
Figure 15. Global Influenza Drugs and Vaccines Sales Market Share by Region in 2020
Figure 16. Global Influenza Drugs and Vaccines Revenue Market Share by Region (2016-2021)
Figure 17. Global Influenza Drugs and Vaccines Revenue Market Share by Region in 2020
Figure 18. Global Influenza Drugs and Vaccines Sales Share by Manufacturer in 2020
Figure 19. The Top 10 and 5 Players Market Share by Influenza Drugs and Vaccines Revenue in 2020
Figure 20. Influenza Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Influenza Drugs and Vaccines Sales Market Share by Type (2016-2021)
Figure 22. Global Influenza Drugs and Vaccines Sales Market Share by Type in 2020
Figure 23. Global Influenza Drugs and Vaccines Revenue Market Share by Type (2016-2021)
Figure 24. Global Influenza Drugs and Vaccines Revenue Market Share by Type in 2020
Figure 25. Global Influenza Drugs and Vaccines Sales Market Share by Application (2016-2021)
Figure 26. Global Influenza Drugs and Vaccines Sales Market Share by Application in 2020
Figure 27. Global Influenza Drugs and Vaccines Revenue Market Share by Application (2016-2021)
Figure 28. Global Influenza Drugs and Vaccines Revenue Market Share by Application in 2020
Figure 29. Japan Influenza Drugs and Vaccines Sales Growth Rate 2016-2027 (MT)
Figure 30. Japan Influenza Drugs and Vaccines Revenue Growth Rate 2016-2027 (US$ Million)
Figure 31. Japan Influenza Drugs and Vaccines Market Share in Global Market 2016-2027
Figure 32. Japan 5 and 10 Largest Influenza Drugs and Vaccines Players Market Share by Revenue in Influenza Drugs and Vaccines in 2020
Figure 33. Japan Influenza Drugs and Vaccines Revenue Share by Type (2016-2021)
Figure 34. Japan Influenza Drugs and Vaccines Revenue Growth Rate by Type in 2016 & 2020
Figure 35. Japan Influenza Drugs and Vaccines Revenue Share by Application (2016-2021)
Figure 36. Japan Influenza Drugs and Vaccines Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Influenza Drugs and Vaccines Sales Growth Rate 2016-2021 (MT)
Figure 38. North America Influenza Drugs and Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
Figure 39. North America Influenza Drugs and Vaccines Sales Market Share by Country in 2020
Figure 40. North America Influenza Drugs and Vaccines Revenue Market Share by Country in 2020
Figure 41. U.S. Influenza Drugs and Vaccines Sales Growth Rate (2016-2021) (MT)
Figure 42. U.S. Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Canada Influenza Drugs and Vaccines Sales Growth Rate (2016-2021) (MT)
Figure 44. Canada Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Europe Influenza Drugs and Vaccines Sales Growth Rate 2016-2021 (MT)
Figure 46. Europe Influenza Drugs and Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
Figure 47. Europe Influenza Drugs and Vaccines Sales Market Share by Country in 2020
Figure 48. Europe Influenza Drugs and Vaccines Revenue Market Share by Country in 2020
Figure 49. Germany Influenza Drugs and Vaccines Sales Growth Rate (2016-2021) (MT)
Figure 50. Germany Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. France Influenza Drugs and Vaccines Sales Growth Rate (2016-2021) (MT)
Figure 52. France Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. U.K. Influenza Drugs and Vaccines Sales Growth Rate (2016-2021) (MT)
Figure 54. U.K. Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. Italy Influenza Drugs and Vaccines Sales Growth Rate (2016-2021) (MT)
Figure 56. Italy Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Russia Influenza Drugs and Vaccines Sales Growth Rate (2016-2021) (MT)
Figure 58. Russia Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Asia Pacific Influenza Drugs and Vaccines Sales Growth Rate 2016-2021 (MT)
Figure 60. Asia Pacific Influenza Drugs and Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
Figure 61. Asia Pacific Influenza Drugs and Vaccines Sales Market Share by Region in 2020
Figure 62. Asia Pacific Influenza Drugs and Vaccines Revenue Market Share by Region in 2020
Figure 63. China Influenza Drugs and Vaccines Sales Growth Rate (2016-2021) (MT)
Figure 64. China Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Japan Influenza Drugs and Vaccines Sales Growth Rate (2016-2021) (MT)
Figure 66. Japan Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. South Korea Influenza Drugs and Vaccines Sales Growth Rate (2016-2021) (MT)
Figure 68. South Korea Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. India Influenza Drugs and Vaccines Sales Growth Rate (2016-2021) (MT)
Figure 70. India Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. Australia Influenza Drugs and Vaccines Sales Growth Rate (2016-2021) (MT)
Figure 72. Australia Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Taiwan Influenza Drugs and Vaccines Sales Growth Rate (2016-2021) (MT)
Figure 74. Taiwan Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Indonesia Influenza Drugs and Vaccines Sales Growth Rate (2016-2021) (MT)
Figure 76. Indonesia Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Thailand Influenza Drugs and Vaccines Sales Growth Rate (2016-2021) (MT)
Figure 78. Thailand Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Malaysia Influenza Drugs and Vaccines Sales Growth Rate (2016-2021) (MT)
Figure 80. Malaysia Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Philippines Influenza Drugs and Vaccines Sales Growth Rate (2016-2021) (MT)
Figure 82. Philippines Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Vietnam Influenza Drugs and Vaccines Sales Growth Rate (2016-2021) (MT)
Figure 84. Vietnam Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Latin America Influenza Drugs and Vaccines Sales Growth Rate 2016-2021 (MT)
Figure 86. Latin America Influenza Drugs and Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
Figure 87. Latin America Influenza Drugs and Vaccines Sales Market Share by Country in 2020
Figure 88. Latin America Influenza Drugs and Vaccines Revenue Market Share by Country in 2020
Figure 89. Mexico Influenza Drugs and Vaccines Sales Growth Rate (2016-2021) (MT)
Figure 90. Mexico Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 91. Brazil Influenza Drugs and Vaccines Sales Growth Rate (2016-2021) (MT)
Figure 92. Brazil Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Argentina Influenza Drugs and Vaccines Sales Growth Rate (2016-2021) (MT)
Figure 94. Argentina Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 95. Middle East and Africa Influenza Drugs and Vaccines Sales Growth Rate 2016-2021 (MT)
Figure 96. Middle East and Africa Influenza Drugs and Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
Figure 97. Middle East and Africa Influenza Drugs and Vaccines Sales Market Share by Country in 2020
Figure 98. Middle East and Africa Influenza Drugs and Vaccines Revenue Market Share by Country in 2020
Figure 99. Turkey Influenza Drugs and Vaccines Sales Growth Rate (2016-2021) (MT)
Figure 100. Turkey Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 101. Saudi Arabia Influenza Drugs and Vaccines Sales Growth Rate (2016-2021) (MT)
Figure 102. Saudi Arabia Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 103. U.A.E Influenza Drugs and Vaccines Sales Growth Rate (2016-2021) (MT)
Figure 104. U.A.E Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 105. Influenza Drugs and Vaccines Value Chain
Figure 106. Channels of Distribution
Figure 107. Distributors Profiles
Figure 108. Bottom-up and Top-down Approaches for This Report
Figure 109. Data Triangulation
Figure 110. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.